These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10708268)

  • 41. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.
    Greenberg BD; Tolliver TJ; Huang SJ; Li Q; Bengel D; Murphy DL
    Am J Med Genet; 1999 Feb; 88(1):83-7. PubMed ID: 10050973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects.
    Slotkin TA; McCook EC; Ritchie JC; Carroll BJ; Seidler FJ
    Biol Psychiatry; 1997 Jan; 41(2):172-83. PubMed ID: 9018387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder.
    Altemus M; Murphy DL; Greenberg B; Lesch KP
    Am J Med Genet; 1996 Jul; 67(4):409-11. PubMed ID: 8837711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression.
    Stain-Malmgren R; Tham A; Aberg-Wistedt A
    J ECT; 1998 Mar; 14(1):15-24. PubMed ID: 9661089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine.
    Akunne HC; de Costa BR; Jacobson AE; Rice KC; Rothman RB
    Neurochem Res; 1992 Dec; 17(12):1275-83. PubMed ID: 1461373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
    Marcusson JO; Ross SB
    Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased density of the platelet serotonin transporter in pathological gamblers.
    Marazziti D; Golia F; Picchetti M; Pioli E; Mannari P; Lenzi F; Conversano C; Carmassi C; Catena Dell'Osso M; Consoli G; Baroni S; Giannaccini G; Zanda G; Dell'Osso L
    Neuropsychobiology; 2008; 57(1-2):38-43. PubMed ID: 18451636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased platelet 3H-paroxetine binding in untreated panic disorder patients.
    Marazziti D; Rossi A; Dell'Osso L; Palego L; Placidi GP; Giannaccini G; Lucacchini A; Cassano GB
    Life Sci; 1999; 65(25):2735-41. PubMed ID: 10622283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decrease of serotonin transporters in blood platelets after epileptic seizures.
    Cupello A; Favale E; Audenino D; Scarrone S; Gastaldi S; Albano C
    Neurochem Res; 2005 Apr; 30(4):425-8. PubMed ID: 16076011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet serotonin transporter density and related parameters in endurance-trained and sedentary male subjects.
    Strachan AT; Maughan RJ
    Acta Physiol Scand; 1998 Jun; 163(2):165-71. PubMed ID: 9648635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
    Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
    Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship of obsessive-compulsive disorder to putative spectrum disorders: results from an Indian study.
    Jaisoorya TS; Reddy YC; Srinath S
    Compr Psychiatry; 2003; 44(4):317-23. PubMed ID: 12923710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
    Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
    Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obsessive-compulsive spectrum disorders in obsessive-compulsive disorder and other anxiety disorders.
    Lochner C; Stein DJ
    Psychopathology; 2010; 43(6):389-96. PubMed ID: 20847586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres.
    Rosel P; Arranz B; Urretavizcaya M; Oros M; San L; Vallejo J; Navarro MA
    Psychiatry Res; 2002 Aug; 111(2-3):105-15. PubMed ID: 12374628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
    Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
    J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
    Stengler-Wenzke K; Müller U; Angermeyer MC; Sabri O; Hesse S
    Eur Arch Psychiatry Clin Neurosci; 2004 Aug; 254(4):252-5. PubMed ID: 15309396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.